The future of precision medicine part 4: diagnosing the diagnostic problem

Amid the excitement around the potential new treatment approaches that precision medicine may yield it is important not to lose sight of the vital pre-condition before any treatment can be selected and applied—the effective and accurate diagnosis of the underlying condition.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Europe

European court backs AstraZeneca unit in blood cancer combo dispute

28 May 2026 A European court dismissed a challenge by a German generics manufacturer, confirming the validity of a patent covering a blood cancer combination therapy.

Europe

Chinese medtech company fined by UPC over injunction breaches

21 May 2026 The court has imposed a financial penalty after finding it continued promoting banned devices online despite an injunction covering five European countries.

Europe

Orrick lands five-member M&A team in Paris

18 May 2026 A high-profile Paris-based partner and four others join the firm, bringing experience across M&A, venture capital and life sciences-focused transactions.

More features

Federal Circuit tosses $59m trade secrets judgment against EOFlow

European court backs AstraZeneca unit in blood cancer combo dispute

Boehringer Ingelheim adds ex-Teva executive to patent team

UPC judge: ‘Expectations of you as a woman are the challenge’

Chinese medtech company fined by UPC over injunction breaches

Kirkland & Ellis subject of alleged conflict in trade secrets clash

Orrick lands five-member M&A team in Paris

IP in the deal room: The risks that bite before, during and after closing

The future of precision medicine part 4: diagnosing the diagnostic problem

More on this story

Editor's picks

Editor's picks

More features